Open AccessFailure to Prevent Severe Graft-Versus-Host Disease in Haploidentical Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide in Chronic Granulomatous Disease
Author(s) -
Mark Parta,
Dianne Hilligoss,
Ciarán P. Kelly,
Nana Kwatemaa,
Narda Theobald,
Christa S. Zerbe,
Steven M. Holland,
Harry L. Malech,
Elizabeth M. Kang
Publication year - 2020
Publication title -
journal of clinical immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.739
H-Index - 96
eISSN - 1573-2592
pISSN - 0271-9142
DOI - 10.1007/s10875-020-00772-z
Subject(s) - medicine , fludarabine , transplantation , cyclophosphamide , graft versus host disease , busulfan , hemorrhagic cystitis , regimen , refractory (planetary science) , aspergillosis , total body irradiation , sirolimus , immunology , surgery , gastroenterology , hematopoietic stem cell transplantation , chemotherapy , biology , astrobiology
Haploidentical related donor (HRD) transplantation was performed in 7 recipients with chronic granulomatous disease (CGD) who had no matched-related or unrelated donor.